Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Alexandra Diaz Pardo"'
Publikováno v:
JCO Oncology Practice. 19:67-69
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5558b33f731770b9aa977aa3d1362ce5
https://doi.org/10.1200/op.22.00798
https://doi.org/10.1200/op.22.00798
Autor:
Yaacov Richard Lawrence, Marcin Miszczyk, Aisling S Barry, Dayssy Alexandra Diaz Pardo, Artur Aguiar, Dror Limon, Raphael M. Pfeffer, Michael Buckstein, Ofer Margalit, Ronen Fluss, Tikva Meron, Adam P. Dicker, Camilla Zimmermann, David Hausner, Ofir Morag, Talia Golan, Laurence S Freedman, Maoz Ben-Ayun, Zvi Symon, Laura A. Dawson
Publikováno v:
Journal of Clinical Oncology. 41:662-662
662 Background: Upper abdominal / lower back pain characterizes celiac plexus involvement from pancreatic and other cancers which may impair HRQOL; its satisfactory treatment is an unmet clinical need. We hypothesized that ablative radiation delivere
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d4d92475f61bc519fe389e33a854271
https://doi.org/10.1200/jco.2023.41.4_suppl.662
https://doi.org/10.1200/jco.2023.41.4_suppl.662
Autor:
Howard P Safran, Kathryn Winter, David H Ilson, Dennis Wigle, Thomas DiPetrillo, Michael G Haddock, Theodore S Hong, Lawrence P Leichman, Lakshmi Rajdev, Murray Resnick, Lisa A Kachnic, Samantha Seaward, Harvey Mamon, Dayssy Alexandra Diaz Pardo, Carryn M Anderson, Xinglei Shen, Anand K Sharma, Alan W Katz, Jonathan Salo, Kara L Leonard, Jennifer Moughan, Christopher H Crane
Publikováno v:
The Lancet. Oncology. 23(2)
Trastuzumab is a monoclonal antibody against HER2 (also known as ERBB2). The primary objective of the NRG Oncology/RTOG-1010 trial was to establish whether trastuzumab improves disease-free survival when combined with trimodality treatment (paclitaxe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a941128886a87cf6b1452d19a978e0b8
https://pubmed.ncbi.nlm.nih.gov/35038428
https://pubmed.ncbi.nlm.nih.gov/35038428
Autor:
Terence M. Williams, Dayssy Alexandra Diaz Pardo, Jose G. Bazan, Eric D. Miller, Alessandra Gasior, Ansel P. Nalin, Emily Huang, A.L.H. Arnett, Pannaga Malalur, Hui-Zi Chen
Publikováno v:
Journal of the National Comprehensive Cancer Network. 20:644-652.e2
Background: The incidence of squamous cell carcinoma of the anus (SCCA) is increasing, particularly among the elderly (age ≥65 years). We sought to compare patterns of care for the treatment of SCCA in elderly versus nonelderly patients. Methods: D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ba1facbeaec2aac12919a491b57f6ed
https://doi.org/10.6004/jnccn.2020.7691
https://doi.org/10.6004/jnccn.2020.7691
Autor:
Ansel P. Nalin, A.L.H. Arnett, Ning Jin, Syed Husain, Jose A. Bazan, Dayssy Alexandra Diaz Pardo, Eric D. Miller, Laith Abushahin, Terence M. Williams
Publikováno v:
Cancers
Volume 12
Issue 11
Cancers, Vol 12, Iss 3248, p 3248 (2020)
Volume 12
Issue 11
Cancers, Vol 12, Iss 3248, p 3248 (2020)
The optimal treatment for stage I squamous cell carcinoma of the anus (SCCA) remains undefined. Recently, wide local excision alone was found to have comparable survival to those treated with chemoradiation (CRT). Given that local excision may be suf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::787e59300f2cc533fb772d05ca24d5b1
Autor:
John L. Hays, Nikhil Sebastian, Anne M. Noonan, Dayssy Alexandra Diaz Pardo, Eric D. Miller, Terence M. Williams
Publikováno v:
Journal of Clinical Oncology. 37:e15659-e15659
e15659 Background: Intrahepatic cholangiocarcinoma (ICC) is an aggressive hepatobiliary malignancy characterized by local infiltration and lymph node, lung, and bone metastases. The majority of patients die from tumor-related liver failure. The stand
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::04c5eb657fcbe9b6a3472c9af46c4f74
https://doi.org/10.1200/jco.2019.37.15_suppl.e15659
https://doi.org/10.1200/jco.2019.37.15_suppl.e15659
Autor:
Laith Abushahin, Mary Dillhoff, Adam R. Wolfe, Jordan M. Cloyd, Terence M. Williams, Anne M. Noonan, Eric D. Miller, Dayssy Alexandra Diaz Pardo, Adrei Manilchuck
Publikováno v:
Journal of Clinical Oncology. 37:4123-4123
4123 Background: In the metastatic or adjuvant setting for pancreatic cancer, the combination chemotherapy of fluorouracil, leucovorin, irinotecan, and oxaliplatin (FOLFIRINOX) resulted in longer overall survival (OS) compared to gemcitabine therapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb5dfa4ba28869eceb1fc77a06689c1c
https://doi.org/10.1200/jco.2019.37.15_suppl.4123
https://doi.org/10.1200/jco.2019.37.15_suppl.4123
Publikováno v:
Journal of Clinical Oncology. 37:673-673
673 Background: There is no randomized prospective evidence to clarify the role of adjuvant radiotherapy in localized colon cancer. Despite this, national consensus guidelines recommend that adjuvant radiotherapy be considered for patients with T4 di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e1a9a243ce85c5d3a7610b793c5a09a
https://doi.org/10.1200/jco.2019.37.4_suppl.673
https://doi.org/10.1200/jco.2019.37.4_suppl.673